Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p22
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 22/36)
Character Range: 371909–374849

animal use containing 2% or less of lauryl sulfates; or

       (e) in other preparations containing 30% or less of lauryl sulfates and, if containing more than 5% of lauryl sulfates, when labelled with warnings to the following effect:

          (i) IF IN EYES WASH OUT IMMEDIATELY WITH WATER; and

          (ii) IF SKIN OR HAIR CONTACT OCCURS, REMOVE CONTAMINATED CLOTHING AND FLUSH SKIN AND HAIR WITH RUNNING WATER.
    LEAD COMPOUNDS except:

       (a) when included in, or expressly excluded from, Schedule 10; or

       (b) in preparations for cosmetic use containing 10 mg/kg or less of lead; or

       (c) in pencil cores, finger colours, showcard colours, pastels, crayons, poster paints/colours or coloured chalks containing 25 mg/kg or less of lead; or

       (d) in ceramic glazes when labelled with the warning statement:

           CAUTION – Harmful if swallowed. Do not use on surfaces which contact food or drink;

        written in letters not less than 1.5 mm in height.
    LEPTOSPERMUM SCOPARIUM OIL (manuka oil) except:

       (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or

       (b) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (c) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (d) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings;

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (e) in preparations containing 25% or less of Leptospermum scoparium oil.
    LEVAMISOLE for the treatment of animals except:

       (a) when included in Schedule 4 or 5; or

       (b) in preparations for the treatment of ornamental birds or ornamental fish, in packs containing 10 mg or less of levamisole.
    LINDANE except when included in Schedule 2, 4 or 5.
    MAFENIDE when packed and labelled for the treatment of ornamental fish only.
    MALATHION except:

       (a) when included in Schedule 5; or

       (b) for human therapeutic use; or

       (c) in dust preparations containing 2% or less of malathion.
    MCPA except when included in Schedule 5.
    MCPB.
    MEBENDAZOLE for the treatment of